Antidepressant prevalence for youths: a multi‐national comparison
Open accessThe DOI matches its Crossref record.
Abstract
Objective: To compare antidepressant prevalence data in youths across three western European countries (Denmark, Germany, and the Netherlands) with US regional data in terms of age and gender and to show proportional subclass antidepressant (ATD) use. Method: A population‐based analysis of administrative claims data for the year 2000 was undertaken in 0 to 19‐year‐old enrollees who were part of the insured populations from four countries having a total of from 72,570 to 480,680 members. Results: ATD medication utilization in the US dataset (1.63%) exceeded that of three Western European countries (prevalence ranged from 0.11 to 0.54%) by at least 3‐fold. There were major variations in the use of subclasses: tricyclic antidepressants (TCAs) predominated in Germany while selective serotonin reuptake inhibitors (SSRIs) predominated in the US, Denmark and the Netherlands. Conclusions: Cross‐national variations should be further explored to understand the factors related to these differences and how prevalence differences relate to effectiveness and safety. Community‐based cohorts should be followed to establish outcomes in the usual practice setting. Copyright © 2006 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Social defeat stress induces a depression-like phenotype in adolescent male c57BL/6 mice
Iñiguez, S. D., Riggs, L. M., Nieto, S. J., Dayrit, G., Zamora, N. N., Shawhan, K. L., Cruz, B., & Warren, B. L. (2014) · Stress · doi:10.3109/10253890.2014.910650 · Cited by 269
“…administration of the antidepressant fluoxetine (Prozac), the only Food and Drug Administration approved pharmaceutical for pediatric depression (Zito et al., 2006), regulates the activation of VTA BDNF-related molecules in an antagonistic manner (Warren et al., 2011; Iñiguez et al., 2014).”
BackgroundA three-country comparison of psychotropic medication prevalence in youth
Zito, J. M., Safer, D. J., Berg, L. T. D. J.-V. D., Janhsen, K., Fegert, J. M., Gardner, J. F., Glaeske, G., & Valluri, S. C. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-26 · Cited by 201
Self-citationDubrall, D., Fekete, S., Leitzen, S., Paschke, L. M., Romanos, M., Schmid, M., Gerlach, M., & Sachs, B. (2023) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-023-00664-z · Cited by 15
“As an example, paroxetine was often prescribed for juvenile depression before 2004 [33, 34] and reported in the black-box warnings in 2004 [35].”
MethodResult
Metadata
- Authors
- Zito, J. M., Tobi, H., de Jong‐van den Berg, L. T. W., Fegert, J. M., Safer, D. J., Janhsen, K., Hansen, D. G., Gardner, J. F., & Glaeske, G.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2006-05-22
- Volume
- 15
- Issue
- 11
- Pages
- 793-798
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W2034858312
- Cited by
- 97
- References
- 0
- FWCI
- 8.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antidepressant prevalence for youths: a multi‐national comparison. https://app.cochat.ai/papers/10.1002/pds.1254
- The paper
- Zito, J. M., Tobi, H., de Jong‐van den Berg, L. T. W., Fegert, J. M., Safer, D. J., Janhsen, K., Hansen, D. G., Gardner, J. F., & Glaeske, G. (2006). Antidepressant prevalence for youths: a multi‐national comparison. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.1254
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.